SCHEMBL29201276

SCHEMBL29201276

COc1cncc(C=NN(C(=O)O)C(C)(C)C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MKNK2 Q9HBH9 2/20 0.40
▸ MAP4K4 O95819 2/20 0.40
▸ ROCK2 O75116 1/20 0.40
▸ PRKACA P17612 1/20 0.40
▸ ROCK1 Q13464 1/20 0.40
▸ DYRK1A Q13627 1/20 0.40
▸ NTRK3 Q16288 1/20 0.40
▸ PKN2 Q16513 1/20 0.40
▸ CLK4 Q9HAZ1 1/20 0.40
▸ STK17A Q9UEE5 1/20 0.40
▸ MKNK1 Q9BUB5 1/20 0.37
▸ SLC22A12 Q96S37 1/20 0.36
▸ G6PC1 P35575 2/20 0.35
▸ PDE4D Q08499 2/20 0.33
▸ PDE4A P27815 1/20 0.33
▸ PDE4B Q07343 1/20 0.33
▸ PDE4C Q08493 1/20 0.33
▸ NPC1 O15118 1/20 0.32
▸ CYP1A2 P05177 4/20 0.32
▸ CYP1A1 P04798 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3489832 0.74 G6PC1 (0.52) G6PC1NPC1
SCHEMBL3490011 0.73 G6PC1 (0.46) ROCK2G6PC1NPC1CYP1A2CYP2D6
SCHEMBL28885499 0.72 CYP1A2 (0.61) MKNK2MAP4K4ROCK2PRKACAROCK1
SCHEMBL21847184 0.72 CYP1A2 (0.61) MKNK2MAP4K4ROCK2PRKACAROCK1
SCHEMBL31015289 0.72 MKNK2 (0.53) MKNK2MAP4K4ROCK2PRKACAROCK1
SCHEMBL5313268 0.72 MKNK2 (0.53) MKNK2MAP4K4ROCK2PRKACAROCK1
SCHEMBL21914766 0.70 RAB9A (0.62) NPC1CYP1A2
SCHEMBL29201275 0.70 RAB9A (0.62) NPC1CYP1A2
SCHEMBL12966330 0.69 MKNK2 (0.46) MKNK2MAP4K4ROCK2PRKACAROCK1
SCHEMBL3488129 0.68 ATM (0.44) NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110914280-B 6H-thieno [2,3-e ] [1,2,4] triazolo [3,4-c ] [1,2,4] triazab derivatives 阿尤米制药公司 2024-05-03 — — CN disclosed
Send feedback